ACG

Annual Scientific Meeting

October 14-16, 2013Ballroom 6

Program Description:
The field of gastroenterology and hepatology continues to see advancements in multiple areas relating to diagnostic measures, therapeutic options and technology. In order to provide appropriate and top-quality patient care, the clinician is challenged to stay abreast of the changes and advancements affecting the management of many gastrointestinal and liver disease states. Throughout the three-day Annual Meeting, you will be exposed to updates in a variety of topics, including IBD, colorectal cancer screening, hepatitis C, managing difficult diarrhea, malpractice issues, esophageal disorders, GERD, IBS, pancreatic conditions, and more.

Eleven scientific plenary symposia will allow attendees to hear lecture presentations from experts and to participate in interactive question and answer sessions with the faculty. In addition, 17 optional scientific breakfast sessions will be offered, where a smaller setting allows for heightened interaction with the speakers and greater audience involvement. Many sessions will use expert panel discussions in debate and case-based formats.

New for ACG’s 3-day Annual Scientific Meeting, Video Forum: The Best ACG Cases of 2013, will feature the best video presentations submitted from colleagues from across the U.S. and around the world. Submitted during ACG’s Call for Abstracts and peer-reviewed and selected for presentation, the cases will feature endoscopy techniques, challenging or unique cases, and cases in the area of GI endoscopy. During the session, the audience, along with the Moderators, will vote to select the best video of ACG 2013.

The program is designed primarily for physicians in gastroenterology and hepatology, as well as physician assistants, nurse practitioners and other advanced practice healthcare professionals interested in the latest information on state-of-the-art treatment of these illnesses.

Accreditation:
The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American College of Gastroenterology designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Monday, October 14, 2013
6:30 am - 6:00 pm

6:00 am – 4:45 pm Registration
(Exhibit Hall Lobby)
6:30 am – 7:45 am Optional Breakfast Sessions
(See ticket for room assignment)

Monday Breakfast Sessions
6:30 am – 7:45 am

Cost is $60 per person/per session. Separate registration required. A syllabus on USB including all ACG 2013 Breakfast Sessions will be provided to
attendees registered for any Breakfast Session.

Breakfast A: Hepatic Challenges for the Community Gastroenterologist
Moderator: Mark W. Russo, MD, MPH, FACG
  • Acute Hepatitis vs. Impending Liver Failure: How to Follow, When to Refer
    Richard K. Sterling, MD, MSc, FACG
    Discuss management of severe liver injury and recognize when hospital admission or referral for transplant evaluation is appropriate.

  • The Incidental Liver Lesion: How to Follow, When to Refer
    Sammy Saab, MD, MPH
    Discuss appropriate evaluation strategies of liver masses detected incidentally and when follow-up imaging is needed.

  • The Potential Liver Transplant Candidate: What Is My Role and What Do I Need to Do Prior to Referral?
    Mark W. Russo, MD, MPH, FACG
    Discuss the responsibilities of the referring gastroenterologist as far as diagnostic testing and surveillance management in the cirrhotic patient undergoing liver transplant evaluation.

Breakfast B: Era of Genetic Medicine
Moderator: Carol A. Burke, MD, FACG

  • ABCs of DNA: A Primer for Gastroenterologists
    Brandie H. Leach, MS, CGC
    Define the different inherited gastrointestinal cancer pathways and understand the risk of phenotypic expression of disease.

  • When to Order Genetic Tests in Your Practice
    Carol A. Burke, MD, FACG
    Understand when to order and how to interpret serologic-based genetic tests in your practice.

  • Genetic GI Disorders: Endoscopic Impact
    Felice Schnoll-Sussman, MD, FACG
    Demonstrate the subtleties and complexities of endoscopic screening and surveillance in patients with hereditary cancer syndromes.

Breakfast C: Small Bowel: Lumps, Bumps and Things That Bleed in the Night
Moderator: Christina A. Tennyson, MD

  • Mining the Small Bowel with Capsule Endoscopy
    Daniel S. Mishkin, MD, FACG
    Interpret and differentiate complicated capsule endoscopy findings.

  • Enterography: The Bird’s Eye View
    Joel G. Fletcher, MD
    Define the role of enterography in the management of small bowel lesions.

  • Enteroscopy Saves the Day
    Christina A. Tennyson, MD
    Demonstrate the role of enteroscopy in the treatment of small bowel lesions.

Breakfast D: Getting a Grip on Nausea and Vomiting
Moderator: Eamonn M. M. Quigley, MD, FACG

  • Getting the Story Right: Differentiating Vomiting, Regurgitation and Rumination
    Eamonn M. M. Quigley, MD, FACG
    Distinguish vomiting, regurgitation and rumination and specify how this differentiation affects management.

  • What to Do with Nausea without Vomiting
    Braden Kuo, MD
    Formulate a diagnostic and treatment approach for chronic nausea without vomiting.

  • Approach to Chronic or Recurrent Vomiting
    William L. Hasler, MD
    Determine a management strategy for chronic nausea and vomiting.
6:00 am – 4:45 pm Registration
(Exhibit Hall Lobby)
7:50 am – 6:00 pm Scientific Meeting
7:50 am – 8:00 am Opening Remarks
Ronald J. Vender, MD, FACG
ACG President
8:00 am – 9:00 am President’s Plenary Session 1
Jonathan A. Leighton, MD, FACG
Ronald J. Vender, MD, FACG
9:00 am – 9:30 am President’s Address
Ronald J. Vender, MD, FACG
9:30 am – 10:30 am President’s Plenary Session 2
Jonathan A. Leighton, MD, FACG
Harry E. Sarles, Jr., MD, FACG
10:00 am – 4:30 pm Exhibit Hall Opens
(Exhibit Halls A-C)
10:00 am – 4:30 pm Hands-on Workshop Center
(Exhibit Halls A-C, Booth #2113)
10:30 am – 11:30 am Break – Visit Exhibits
(Exhibit Halls A-C)
10:30 am – 11:30 am Exhibitor Theater
(Exhibit Halls A-C, Booth #1801)

Simultaneous Symposia 1
11:30 am – 12:45 pm

Simultaneous Symposia 1A: Management of Incurable Esophageal Disorders
Moderator: David A. Katzka, MD, FACG

  • Maintenance Therapies in Eosinophilic Esophagitis
    David A. Katzka, MD, FACG
    Define the role of maintenance strategies in patients with eosinophilic esophagitis.

  • GERD: Management of Chronic Symptoms and Complications
    Joel E. Richter, MD, MACG
    Describe the long term management of GERD.

  • Achalasia/Spasm: Today and Tomorrow
    C. Prakash Gyawali, MD, FACG
    Describe the current and future diagnostic and therapeutic tools of achalasia and esophageal spastic disorders.

Simultaneous Symposia 1B: The Future of IBD Treatment: 2013 and Beyond
Moderator: Ernest G. Seidman, MD, FACG

  • Personalized Medicine in IBD
    Ernest G. Seidman, MD, FACG
    Develop an understanding of the available genetic, serologic and drug levels.

  • What to Do When Anti-TNFs Don’t Work
    Bruce E. Sands, MD, FACG
    Formulate a treatment strategy when patients do not respond to anti-TNFs.

  • Quality of Care in IBD in 2013
    Thomas A. Ullman, MD, FACG
    Identify quality measures in IBD.
12:45 pm – 1:30 pm Exhibitor Theater
(Exhibit Halls A-C, Booth #1801)
12:45 pm – 2:15 pm Lunch Break – Visit Exhibits
(Exhibit Halls A-C)
12:45 pm – 2:15 pm Poster Session
(Exhibit Halls A-C)
12:45 pm – 2:15 pm NP/PA Luncheon Session
(Room 4)
1:45 pm – 2:15 pm Exhibitor Theater
(Exhibit Halls A-C, Booth #1801)

Simultaneous Plenary Sessions
2:15 pm – 3:00 pm

Plenary Session 1: Colon
Moderators: Joseph C. Anderson, MD, and Michael B. Wallace, MD, MPH, FACG

Plenary Session 2: Pediatrics / Outcomes
Moderators: Lauren B. Gerson, MD, FACG, and Timothy B. Gardner, MD, FACG

3:00 pm – 3:45 pm

The American Journal of Gastroenterology Lecture:
The Emerging Role of the Microbiome in the Pathogenesis and Management of Inflammatory Bowel Disease
David T. Rubin, MD, FACG, and Stephen M. Collins, MBBS

Determine how the gut microbiome influences health and disease.

3:45 pm – 4:40 pm Break – Visit Exhibits
(Exhibit Halls A-C)
3:35 pm – 4:30 pm Exhibitor Theater
(Exhibit Halls A-C, Booth #1801)
3:55 pm – 4:35 pm

Changes to ABIM’s Maintenance of Certification Program (Room 5AB)
Attend this informational session to understand how the changes to ABIM’s MOC Program requirements affect you.

Simultaneous Symposia 2
4:45 pm – 6:00 pm

Simultaneous Symposia 2A: IBS or Not?
Moderator: Sheila E. Crowe, MD, FACG

  • Food Intolerances and IBS: Coexistent or Separate Entities?
    Sheila E. Crowe, MD, FACG
    Describe the approach to determine whether food intolerances coexist with irritable bowel syndrome or are separate entities and how best to manage patients.

  • Implications of Gluten Intolerance and Celiac Disease in IBS
    Joseph A. Murray, MD, FACG
    Discuss the approach of identifying the presence of gluten intolerance and celiac disease in patients with IBS-like symptoms and how best to manage them.

  • Overlap of IBS in IBD
    Eamonn M. M. Quigley, MD, FACG
    Distinguish if IBS contributes to persistent symptoms in patients with treated or inactive IBD and discuss the mechanisms and treatment for patients with coexistent IBS and IBD.

Simultaneous Symposia 2B: Update for HCV in 2013
Moderator: Mitchell L. Shiffman, MD, FACG

  • New Treatments Approved and Awaiting Approval for Genotype 1 HCV
    David E. Bernstein, MD, FACG
    Review new and awaiting treatment paradigms for genotype 1 HCV.

  • New Treatments Approved and Awaiting Approval for Genotype 2 and 3 HCV
    Norah A. Terrault, MD, MPH, FACG
    Review the combination of polymerase inhibitor plus ribavirin therapy which may be approved by the FDA for genotype 2 and 3 in 2013.

  • Interferon: Old Fad or Here to Stay?
    Mitchell L. Shiffman, MD, FACG
    Discuss the role of interferon based therapy in the era of polymerase inhibitors.
Simultaneous Symposia 2C: Video Forum: The Best ACG Cases of 2013
Moderators: David A. Greenwald, MD, FACG, Seth A. Gross, MD, FACG, and John R. Saltzman, MD, FACG

New for ACG’s 3-day Annual Scientific Meeting, Video Forum: The Best ACG Cases of 2013, will feature the best video presentations submitted from colleagues from across the U.S. and around the world. Submitted during ACG’s Call for Abstracts and peer-reviewed and selected for presentation, the cases will feature endoscopy techniques, challenging or unique cases, and cases in the area of GI endoscopy. During the session, the audience, along with the Moderators, will vote to select the best video of ACG 2013.

6:00 pm – 7:00 pm Annual Business Meeting and Reception Honoring the ACG President (Ballroom 6A)
College Members & Fellows invited
Tuesday, October 15
6:45 am – 6:15 pm

6:00 am – 5:00 pm Registration
(Exhibit Hall Lobby)
6:45 am – 8:15 am Optional Breakfast Sessions
(See ticket for room assignment)

Tuesday Breakfast Sessions
6:45 am – 8:15 am

Cost is $60 per person/per session. Separate registration required. A syllabus on USB including all ACG 2013 Breakfast Sessions will be provided to
attendees registered for any Breakfast Session.

Breakfast E: Elementary IBD: Treating the Adolescent
Moderators: Joel R. Rosh, MD, FACG and Marsha H. Kay, MD, FACG

  • Psychosocial Adjustments and Transitioning the Adolescent IBD Patient from Pediatric GI to Adult GI
    Eva Szigethy, MD, PhD
    Assess the importance of psychosocial adjustments when transitioning a pediatric patient with IBD from the pediatrician to the adult gastroenterologist.

  • Hepatosplenic T-cell Lymphoma and Other Concerns for the Adolescent Patient with IBD in the Era of Biologics
    Joel R. Rosh, MD, FACG
    Discuss the recent data regarding risk factors for lymphoma and other complications that have emerged in the biologic era including the risks and benefits of concurrent immunomodulator therapy for pediatric patients on biologic therapy.

  • Health Maintenance and Measuring Quality of Life for the Pediatric IBD Patient
    Anthony R. Otley, MD
    Examine health maintenance issues unique to adolescent IBD patients.

Breakfast F: Challenges in the Management of Nonalcoholic Fatty Liver Disease
Moderator: Manal F. Abdelmalek, MD, MPH

  • NAFLD and Autoimmune Overlap Syndrome
    Zobair M. Younossi, MD, MPH, FACG
    Differentiating between NAFLD with positive autoimmune markers vs. true autoimmune hepatitis (AIH) in patients with co-existent obesity. How to define the disease process and when to treat for questionable autoimmune hepatitis.

  • Management of the Lean NAFLD Patient
    Manal F. Abdelmalek, MD, MPH
    Discuss the approach to the evaluation and management of lean patients with NAFLD when weight-loss recommendations are not indicated.

  • When Weight Loss Efforts Don’t Work: What Next?
    Paul Angulo, MD, FACG
    Discuss alternative approaches to management when weight loss alone is ineffective, including the role of current FDA approved therapies for weight loss and when to consider bariatric surgery.

Breakfast G: Bad Day in the Endo Unit
Moderator: Joseph C. Anderson, MD

  • The Difficult and Incomplete Colonoscopy: What Now?
    Joseph C. Anderson, MD
    Identify difficulties in colonoscopy and apply techniques/methods to overcome them.

  • Sub-Optimal Prep: Good Enough or Repeat Exam?
    Philip S. Schoenfeld, MD, MSEd, MScEpi, FACG
    Identify methods to reduce the incidence of sub-optimal preps and review strategies for repeating exams.

  • Polypectomy Gone Bad: What to Do?
    Michael B. Wallace, MD, MPH, FACG
    Describe methods to address complications related to polypectomy.

Breakfast H: Interventional (Therapeutic) Esophagology
Moderator: Francisco C. Ramirez, MD, FACG

  • Dilation: Stretching to the Limit
    Hong Xu, MD, PhD
    Define the different dilation techniques in the management of esophageal disorders.

  • Managing Misadventures in the Esophagus
    Francisco C. Ramirez, MD, FACG
    Describe the diagnostic and therapeutic approaches of suspected/confirmed complications in the esophagus.

  • ESD/POEM: How, When, Where?
    Enqiang Linghu, PhD
    Describe the indications and technical aspects of ESD and POEM.

Breakfast I: Review of Esophageal Function Tests
Moderator: Marcelo F. Vela, MD, MSCR, FACG

  • Overview of HRM: Motor Disorders Beyond the Chicago Classification
    Edy Soffer, MD, FACG
    Describe the manometric features of esophageal motor disorders.

  • Ambulatory Reflux Testing
    Marcelo F. Vela, MD, MSCR, FACG
    Review and define the role of ambulatory tests of GERD.

  • New Techniques for Extraesophageal Reflux
    Kenneth R. DeVault, MD, FACG
    Review the newest diagnostic tests for extraesophageal manifestations of GERD.

Breakfast J: Clinical Pearls in the Management of FGIDs
Moderator: Anthony J. Lembo, MD

  • Functional Dyspepsia
    Brian E. Lacy, MD, PhD, FACG
    Distill the complexities of the diagnosis and treatment of functional dyspepsia into the key clinical pearls.

  • IBS
    Anthony J. Lembo, MD
    Discuss clinical pearls that are helpful in optimizing the diagnosis and treatment of irritable bowel syndrome.

  • Refractory Abdominal Pain
    Albena D. Halpert, MD
    Distinguish organic from functional causes of severe chronic abdominal pain and provide clinical guidance on managing patients with chronic abdominal pain.

Breakfast K: “Houston We Have a Problem:” Stopping or Continuing IBD Treatment in the Face of Adverse Events
Moderator: Gary R. Lichtenstein, MD, FACG

  • Malignancy: Should We Stop or Start Immunomodulators/Anti-TNFs?
    Raymond K. Cross, Jr., MD, MS
    Describe the various adverse events associated with IBD treatments and decide when to stop treatment in the setting of a malignancy.

  • IBD Is Only Skin Deep: Skin Reactions to IBD and Medications
    Gary R. Lichtenstein, MD, FACG
    Understand the various types of skin reactions related to IBD medications and when stopping treatment is necessary.

  • Infections: Managing Immune Suppressive Medications in the Setting of Infection
    Russell D. Cohen, MD, FACG
    Define patient characteristics and clinical scenarios to guide the management of immune suppresive medications in the setting of infections.

Breakfast L: Advanced Endoscopy 101: Yes, You Can – Didactic and Hands-on Learning Experience
Moderator: Seth A. Gross, MD, FACG

If registering for this Breakfast Session, please note that the didactic lectures run through 8:15 am and hands-on will immediately follow in the ACG Hands-on Workshop Center located in the Exhibit Hall.

  • Ablation of Barrett’s Esophagus
    Herbert C. Wolfsen, MD, FACG
    Compare the various Barrett’s ablation techniques and learn how to use them.

  • Enteral Stenting
    Seth A. Gross, MD, FACG
    Distinguish the different types of enteral stents and how to use them.

  • Endoscopic Mucosal Resection for the Beginner
    Christopher J. DiMaio, MD
    Apply endoscopic mucosal resection in your practice.
6:00 am – 5:00 pm Registration
(Exhibit Hall Lobby)
8:30 am – 6:15 pm Scientific Meeting

Simultaneous Plenary Sessions
8:30 am – 10:00 am

Plenary Session 1: Colorectal Cancer Prevention / IBD (Part 1)
Moderators: Amit M. Rastogi, MD, and Miguel D. Regueiro, MD, FACG

Plenary Session 2: Endoscopy / Functional Bowel Disorders
Moderators: John R. Saltzman, MD, FACG, and Jonathan M. Buscaglia, MD

10:00 am – 10:30 am

J. Edward Berk Distinguished Lecture (Ballroom 6A)
Avoiding Burnout: Finding Balance Between Work and Everything Else
Christina M. Surawicz, MD, MACG

Learn to thrive, not just survive, using strategies to detect, treat, and prevent professional burnout.

10:00 am – 4:30 pm Exhibit Hall Opens
(Exhibit Halls A-C)
10:00 am – 4:30 pm Hands-on Workshop Center
(Exhibit Halls A-C)
10:30 am – 11:30 am Break – Visit Exhibits
(Exhibit Halls A-C)

Simultaneous Symposia 3
11:30 am – 12:45 pm

Simultaneous Symposia 3A: What Are the Hot Pancreas Pearls for My Practice in 2013?
Moderator: Santhi Swaroop Vege, MD, FACG

  • New Classification, New Guidelines for Acute Pancreatitis
    Santhi Swaroop Vege, MD, FACG
    Diagnose, predict, classify, assess, determine and treat patients with acute pancreatitis.

  • Chronic Pancreatitis: Pills, Stent, Cut or Transplant and the New American Guidelines
    Darwin L. Conwell, MD, MS
    Diagnose, predict, assess and determine the best modality of treatment.

  • Cancers – Adenocarcinoma and Neuroendocrine: Screening High Risk Groups and New Neuroendocrine Tumor Guidelines
    Robert C. Kurtz, MD, FACG
    Diagnose, stage and determine the role of screening high risk groups and follow new guidelines for diagnosis and treatment of neuroendocrine tumors.
Simultaneous Symposia 3B: Quality and Colonoscopy
Moderator: Aasma Shaukat, MD, MPH, FACG
  • Quality Reporting Is Here: What This Means for You
    David A. Johnson, MD, FACG
    Interpret PQRS and healthcare reform requirements and review resources for what to measure and how.

  • Technology and Interventions to Improve ADR
    Aasma Shaukat, MD, MPH, FACG
    Identify the goals of ADR and review the role of technology and interventions geared towards improving ADRs for low performers.

  • Controversies in Screening and Surveillance Guidelines
    Douglas J. Robertson, MD, MPH
    Discuss if 10 year interval for screening may be too long, and review controversies with surveillance guidelines.
12:45 pm – 1:15 pm ACG Theater
(Exhibit Halls A-C, Booth #1801)
12:45 pm – 2:15 pm Lunch Break – Visit Exhibits
(Exhibit Halls A-C)
12:45 pm – 2:15 pm Poster Session
(Exhibit Halls A-C)
1:30 pm – 2:00 pm ACG Theater
(Exhibit Halls A-C, Booth #1801)

Simultaneous Plenary Sessions
2:15 pm – 3:45 pm

Plenary Session 1: Liver
Moderators: Zobair M. Younossi, MD, FACG, and Kris V. Kowdley, MD, FACG

Plenary Session 2: Esophagus / Stomach
Moderators: Nicholas J. Shaheen, MD, MPH, FACG, and Neena S. Abraham, MD, MSCE, FACG

3:45 pm – 4:30 pm Break – Visit Exhibits
(Exhibit Halls A-C)
3:45 pm – 4:30 pm Exhibitor Theater
(Exhibit Halls A-C, Booth #1801)
4:30 pm – 5:00 pm

Emily Couric Memorial Lecture (Ballroom 6A)
Can We Prevent Cancer in Barrett’s Esophagus?
Nicholas J. Shaheen, MD, FACG

Understand the epidemiology of esophageal adenocarcinoma, state the evidence supporting endoscopic screening and surveillance of Barrett’s esophagus, and know the novel methods of endoscopic screening and surveillance.

Sponsored by the ACG, the Virginia Gastroenterological Society and the Old Dominion Society of Gastroenterology Nurses and Associates

Simultaneous Symposia 4
5:00 pm – 6:15 pm

Simultaneous Symposia 4A: What’s New in GI Bleeding
Moderator: John R. Saltzman, MD, FACG
  • Assessment, Triage and Timing of Endoscopy
    John R. Saltzman, MD, FACG
    Apply the new recommendations for transfusion goals and risk stratification in GI bleeding to improve patient triage.

  • Medical and Endoscopic Management of Upper GI Bleeding
    David A. Greenwald, MD, FACG
    Apply the latest guidelines for medical management and perform current recommended endoscopic treatments to patients with GI bleeding.

  • Obscure and Mysterious GI Bleeding: What Test to Order and When
    Jonathan A. Leighton, MD, FACG
    Apply the latest available information to choose the best test in managing patients with obscure GI bleeding.
Simultaneous Symposia 4B: Difficult Diarrheas: Running on Empty
Moderator: Lawrence R. Schiller, MD, FACG
  • Enteropathies: When the Mucosa Isn’t Working
    Carol E. Semrad, MD, FACG
    Understand the principles of normal fluid and electrolyte intestinal absorption; Diagnose and manage diseases that damage the small bowel mucosa.

  • Bacterial Overgrowth: Getting the Bugs Out
    Lawrence R. Schiller, MD, FACG
    Understand the adverse effect of bacterial growth on digestion and absorption; Recognize and manage diseases that predispose to bacterial overgrowth.

  • Bile Acid Malabsorption: When Detergents Are Too Much
    Joseph H. Sellin, MD, FACG
    Learn new mechanisms by which bile salts cause diarrhea; Diagnose and manage the different types of bile acid diarrhea.
Wednesday, October 16
6:45 am – 12:15 pm

6:00 am – 12:15 pm Registration
(Exhibit Hall Lobby)
6:45 am – 8:15 am Optional Breakfast Sessions
(See ticket for room assignment)

Wednesday Breakfast Sessions
6:45 am – 8:15 am

Cost is $60 per person/per session. Separate registration required. A syllabus on USB including all ACG 2013 Breakfast Sessions will be provided to
attendees registered for any Breakfast Session.

Breakfast M: Practical Nutrition: Hospitalized Patient
Moderator: Robin B. Mendelsohn, MD
  • Trouble Shooting the Dysfunctional Gut
    Robin B. Mendelsohn, MD
    Identify common causes of gastric and intestinal dysfunction in hospitalized patients.

  • Enteral/Parenteral Nutrition: When to Start
    John K. DiBaise, MD, FACG
    Identify malnutrition and recognize when parenteral and enteral nutrition are needed.

  • Tubes and Pancreatitis
    Andres Gelrud, MD
    Evaluate the utility of enteral feeding in pancreatitis.
Breakfast N: Updated Guidelines in GI Motility Disorders
Moderator: C. Prakash Gyawali, MD, FACG
  • Esophageal Motor Disorders
    C. Prakash Gyawali, MD, FACG
    Review the latest practice guidelines for the diagnosis and treatment of esophageal motility disorders.

  • Gastroparesis
    Kenneth L. Koch, MD, FACG
    Discuss and review the application of the latest practice guidelines for the diagnosis and treatment of gastroparesis.

  • Constipation
    Brian E. Lacy, MD, PhD, FACG
    Review and apply the newest practice guidelines for the management of constipation.
Breakfast O: Staying Out of Trouble in Endoscopy
Moderator: Douglas G. Adler, MD, FACG
  • Anti-Coagulants, Anti-Platelet Agents and Endoscopy
    Neena S. Abraham, MD, MSCE, FACG
    Incorporate the latest information on new and existing anti-coagulant and anti-platelet medications to optimally manage patients undergoing endoscopic procedures.

  • Oops, Now What? How to Manage Complications During Endoscopy
    Qiang Cai, MD, PhD, FACG
    Recognize and apply new endoscopic techniques to manage complications of endoscopy including perforation.

  • How to Mitigate the Legal Risk of an Endoscopic Complication
    Douglas G. Adler, MD, FACG
    Develop effective techniques to minimize legal risks and identify appropriate strategies to deal with legal problems when they arise.
Breakfast P: Challenges in Variceal Bleeding
Moderator: Mark W. Russo, MD, MPH, FACG
  • Best Timing for TIPS for Variceal Bleeding
    Thomas D. Schiano, MD
    Review data on TIPS and endoscopic banding for acute and recurrent esophageal and gastric variceal bleeding.

  • Endoscopic Therapy for Varices: Glue and Beyond
    Vijay H. Shah, MD, FACG
    Discuss short and long term data of endoscopic glue therapy for gastric varices.

  • Variceal Bleeding with Portal Vein Thrombosis: What Next?
    Mark W. Russo, MD, MPH, FACG
    Discuss the role of surgical shunts in the era of TIPS.
Breakfast Q: Refractory GERD
Moderator: Marcelo F. Vela, MD, MSCR, FACG
  • Is a Non-Responder, Refractory GERD?
    Brennan M. Spiegel, MD, MSHS, FACG
    Identify and contrast the non-responsive and refractory patient to GERD therapy.

  • Does Identifying Non-Acid Reflux Matter?
    Marcelo F. Vela, MD, MSCR, FACG
    Define the implications of non-acid reflux in clinical practice.

  • Tailoring Treatment Beyond Acid Suppression
    Lauren B. Gerson, MD, FACG
    Define the functional heartburn patient and describe the non-acid suppression therapeutic approaches.
6:00 am – 12:15 pm Registration
(Exhibit Hall Lobby)
8:30 am – 12:15 pm Scientific Meeting

Simultaneous Plenary Sessions
8:30 am – 10:15 am

Plenary Session 1: Small Intestine / Pancreatico-Biliary
Moderators: Darwin L. Conwell, MD, MS, and Carol E. Semrad, MD, FACG

Plenary Session 2: IBD
Moderators: Stephen B. Hanauer, MD, FACG, and David T. Rubin, MD, FACG

10:15 am – 10:45 am

David Y. Graham Lecture (Ballroom 6A)
Leadership in Medicine 2013: Do We Need a New Approach?
Eamonn M. M. Quigley, MD, FACG

Know what organizational and governance changes have occurred in the medical environment and how leadership styles can successfully adapt to this new context; be able to implement a number of methods to improve leadership capabilities, and understand the fundamental importance of communication to good leadership.

10:45 am – 11:00 am Break

Simultaneous Symposia 5
11:00 am – 12:15 pm

Simultaneous Symposia 5A: Debate – Where’s the Finish Line? The Moving Target of IBD Treatment Endpoints
Moderator: Miguel D. Regueiro, MD, FACG
  • Case Presentation
    Miguel D. Regueiro, MD, FACG
    Learn the differences in outcomes for treating to symptom improvement compared with mucosal healing.

  • Treat to Symptoms
    William J. Tremaine, MD, FACG
    Describe outcomes of IBD treatment endpoints and explain the role of symptom response.

  • Treat to Target
    David T. Rubin, MD, FACG
    Specify the various indices utilized to determine treatment success in IBD (clinical, biomarkers, and mucosal healing).
Simultaneous Symposia 5B: Malpractice Issues for the Gastroenterologist
Moderator: John Baillie, MB, ChB, FACG
  • The Risk of Supervising Mid-level Providers: What You Need to Know
    Andrew D. Feld, MD, JD, FACG
    Understand the medico-legal risk of supervising non-physicians.

  • Stopping Anti-Platelet Agent: Will You Cause a Stroke?
    Glenn M. Eisen, MD
    Review the risks of stopping anti-coagulation for elective procedures.

  • How to Professionally and Personally Survive a Malpractice Suit
    John Baillie, MB, ChB, FACG
    Establish strategies to deal with the emotional and professional aspects of a lawsuit.
12:15 pm Annual Scientific Meeting Adjourns